Circio logoCircio logo

  • About
    About
    Close
      • About Circio
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
  • circRNA
    circRNA
    Close
      • Circio AB
      • circVec platform
  • Clinical programs
    Clinical programs
    Close
      • ONCOS-102
      • KRAS program
      • Publications
  • Partnering
  • Investors
    Investors
    Close
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
      • Contact
  • Media
    Media
    Close
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    Contacts
    Close
      • Offices
      • Investors & Media
    • About
      • About Circio
      • Our pipeline
      • Management Team
      • Board of Directors
      • Collaborations
      • Careers
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • ONCOS-102
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Articles of Association
      • Contact
      • Subscribe
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    2017
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • All years
    All subjects
    • Corporate news
    • Other
    December 18, 2017
    Press release - Regulatory

    Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer

    December 13, 2017
    Press release - Non-regulatory

    Targovax to present at DNB healthcare conference

    December 11, 2017
    Press release - Regulatory

    Targovax announces that first combination trials with ONCOS-102 have passed their initial, planned, independent safety reviews

    November 30, 2017
    Press release - Regulatory

    Targovax ASA: New member of the board of directors

    November 14, 2017
    Press release - Regulatory

    Targovax to present at upcoming investor conferences

    November 7, 2017
    Press release - Regulatory

    Targovax ASA: Notice of Extraordinary General Meeting

    November 3, 2017
    Press release - Regulatory

    Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA

    November 2, 2017
    Press release - Regulatory

    Targovax ASA: Third quarter 2017 results

    October 27, 2017
    Press release - Regulatory

    Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

    October 24, 2017
    Press release - Regulatory

    Targovax ASA: Invitation to third quarter 2017 results presentation Thursday 2 November

    October 12, 2017
    Press release - Regulatory

    Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer

    October 3, 2017
    Press release - Regulatory

    Targovax granted US Patent for mutant-RAS neoantigen platform 2nd generation product TG02

    September 25, 2017
    Press release - Regulatory

    Targovax granted US Patent for mutant-RAS neoantigen platform lead products

    September 14, 2017
    Press release - Regulatory

    Targovax Receives 2017 Nordic Stars Award

    September 12, 2017
    Press release - Regulatory

    Targovax announces start of patient recruitment in phase I/II study with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies

    September 11, 2017
    Press release - Non-regulatory

    Targovax ASA: Three posters presented at ESMO conference

    August 29, 2017
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units

    August 28, 2017
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

    August 25, 2017
    Press release - Regulatory

    Exercise of employee share options and restricted stock units in Targovax ASA

    August 24, 2017
    Press release - Regulatory

    Targovax ASA: Second quarter and first half 2017 results

    August 23, 2017
    Press release - Non-regulatory

    Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress

    August 18, 2017
    Press release - Regulatory

    Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

    August 14, 2017
    Press release - Regulatory

    Targovax ASA: Invitation to second quarter and first half 2017 results presentation Thursday 24 August

    July 17, 2017
    Press release - Regulatory

    Targovax ASA: Final result of the subsequent offering

    July 14, 2017
    Press release - Regulatory

    Targovax ASA: Preliminary result of the subsequent offering

    July 14, 2017
    Press release - Regulatory

    Targovax ASA: Last day of the subscription period in the subsequent offering

    July 7, 2017
    Press release - Regulatory

    Targovax ASA: Notification of trade by primary insiders

    July 6, 2017
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following the private placement

    July 3, 2017
    Press release - Regulatory

    Targovax ASA: Commencement of subscription period for the subsequent offering

    June 30, 2017
    Press release - Regulatory

    Targovax ASA: Approval and publication of prospectus; the subsequent offering

    June 30, 2017
    Press release - Regulatory

    Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering

    June 26, 2017
    Press release - Regulatory

    Targovax ASA: Registration of capital increase following exercise of employee options and settlement of restricted stock units

    June 22, 2017
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in relation to exercise of employee options

    June 22, 2017
    Press release - Regulatory

    Targovax ASA: Exercise of employee share options and settlement of restricted stock units in Targovax ASA

    June 15, 2017
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of vested restricted stock units

    June 14, 2017
    Press release - Regulatory

    Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

    June 9, 2017
    Press release - Regulatory

    Targovax ASA: Notice of Extraordinary General Meeting

    June 9, 2017
    Press release - Regulatory

    Targovax ASA – Information on the subsequent offering – Key date information

    June 8, 2017
    Press release - Regulatory

    TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

    June 8, 2017
    Press release - Regulatory

    TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

    June 6, 2017
    Press release - Regulatory

    Targovax presents further positive clinical data from TG01 phase I/II trial at 2017 ASCO annual meeting

    June 6, 2017
    Press release - Regulatory

    Targovax announces formal agenda for 2017 Capital Markets Updates in Oslo and London

    May 18, 2017
    Press release - Regulatory

    Targovax ASA: ASCO abstract released

    May 10, 2017
    Press release - Regulatory

    Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study

    May 8, 2017
    Press release - Regulatory

    Targovax ASA: Capital Markets Updates in Oslo on Thursday 8 June and in London on Monday 26 June 2017

    April 28, 2017
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock unites (RSUs) to the board members

    April 25, 2017
    Press release - Regulatory

    Targovax ASA: First quarter 2017 results

    April 20, 2017
    Press release - Regulatory

    Targovax initiates first clinical trial with TG02, the second product from its RAS-peptide immunotherapy platform

    April 19, 2017
    Press release - Regulatory

    Targovax ASA: Invitation to first quarter 2017 results presentation Tuesday 25 April

    April 6, 2017
    Press release - Regulatory

    Targovax to present clinical data on its phase I/II clinical trial evaluating TG01 in resected pancreatic cancer at the ASCO Annual Meeting

    April 5, 2017
    Press release - Regulatory

    Targovax ASA: Protocol from the Annual General Meeting

    April 4, 2017
    Press release - Regulatory

    Targovax ASA: Proposal from the nomination committee to the annual general meeting 5 April 2017

    April 4, 2017
    Press release - Regulatory

    Targovax ASA: Grant of share options

    March 23, 2017
    Press release - Regulatory

    Targovax ASA moves share listing to Oslo Børs

    March 22, 2017
    Press release - Regulatory

    Targovax ASA: Approval and publication listing prospectus

    March 22, 2017
    Press release - Regulatory

    Targovax ASA: The board of directors of Oslo Stock Exchange approves transfer of Targovax ASA to the main list

    March 17, 2017
    Press release - Regulatory

    Targovax ASA applies for transfer to Oslo Stock Exchange main list

    March 15, 2017
    Press release - Regulatory

    Targovax ASA: Notice of Annual General Meeting

    March 15, 2017
    Press release - Regulatory

    Targovax ASA: Annual Report 2016

    March 6, 2017
    Press release - Non-regulatory

    Targovax to present at upcoming conferences

    February 24, 2017
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units

    February 24, 2017
    Press release - Regulatory

    Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA

    February 16, 2017
    Press release - Regulatory

    Targovax ASA: Fourth quarter and full year 2016 results

    February 13, 2017
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of restricted stock units

    February 10, 2017
    Press release - Regulatory

    Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

    February 6, 2017
    Press release - Regulatory

    Targovax ASA: Invitation to fourth quarter and full year 2016 results presentation Thursday 16 February

    February 2, 2017
    Press release - Regulatory

    Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients

    January 5, 2017
    Press release - Regulatory

    Targovax announces appointment of Erik Digman Wiklund as CFO

    IR contact
    Dr Lubor Gaal
    Dr Lubor Gaal
    Chief Financial Officer
    lubor.gaal@circio.com
    (+34) 683 343 811
    Renate Birkeli
    Renate Birkeli
    Investor Relations
    renate.birkeli@circio.com
    (+47) 922 61 624
    • PRINT
    • STAY CONNECTED
    • Cookies
    • Privacy policy